The global AI in Drug Discovery market size in 2023 is 1506.3 million US dollars, and it is expected to be 9200.2 million US dollars by 2030, with a compound annual growth rate of 29.5% expected in 2024-2030.

MARKET COMPETITIVE LANDSCAPE:
The main players in the AI in Drug Discovery market include GNS Healthcare (US), BioSymetrics (US), BPGbio, Inc (US), Atomwise Inc (US), and Insitro (US). The share of the top 3 players in the AI in Drug Discovery market is XX%.

REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of AI in Drug Discovery market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:
The report segments the market by Type and Application. Software accounted for XX% of AI in Drug Discovery market in 2023. Service share of XX%.
Target Selection and Validation accounted for XX% of the AI in Drug Discovery market in 2023. Drug Screening and Lead Optimization accounts for XX%.

This AI in Drug Discovery market report provides detailed information on latest developments, trade regulations, value chain optimization, market share, impact of domestic and local market players, analyzes emerging revenue sources, market regulation changes Opportunities in Aspects, Strategic Market Growth Analysis, Market Size, Category Market Growth, Application Areas and Dominance, Product Approvals, Product Launches, Geographic Expansion, Technological Innovations in the Market.

AI in Drug Discovery market country level analysis
The countries covered in the AI in Drug Discovery market report include the United States, Canada, Germany, United Kingdom, France, Russia, Japan, China, India, South Korea, Brazil, UAE, Saudi Arabia, etc.
The presence and availability of global brands and challenges due to intense or scarce competition from local and domestic brands, and trade routes are also considered while providing the predictive analysis of country data.

Competitive Landscape and AI in Drug Discovery Market Share Analysis
AI in Drug Discovery market competitive landscape provides details by competitors. The detailed information includes company profile, company financials, revenue generated, market potential, R&D investments, new market plans, global reach. The data points presented above relate only to companies relevant to the AI in Drug Discovery market.

Chapter Outline
Chapter 1: Introduces the product overview, market scope, product classification, and application division, and then includes research purposes, report timeline, and economic analysis of global regions.
Chapters 2-7: Provide Global, North America, Europe, Asia-Pacific, Latin America and Middle East & Africa AI in Drug Discovery market type, application, player and country market segmentation data.
Chapters 8-9: Segmented the global AI in Drug Discovery market by type, and application. Analyze the revenue of market segments from different perspectives.
Chapter 10: Introduces the market dynamics, the trends factors and drivers factors of the market, and the challenges and restraints faced by manufacturers in the industry, and includes industry mergers & acquisitions and industry new entrants and expansion plans.
Chapter 11: Analyzes the main companies in the AI in Drug Discovery industry, including their main businesses, products/services, revenue, gross and gross margin.
Chapter 12: The main points and conclusions of the report.

Highlights-Regions

North America
United States
Canada
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Nordic
South America
Brazil
Argentina
Colombia
Mexico
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Player list
GNS Healthcare (US)
BioSymetrics (US)
BPGbio, Inc (US)
Atomwise Inc (US)
Insitro (US)
NVIDIA Corporation (US)
IBM Corporation (US)
Microsoft Corporation (US)
Aria Pharmaceuticals, Inc. (US)
Insilico Medicine (US)
NuMedii, Inc. (US)
Owkin Inc. (US)
Schrödinger, Inc. (US)
DEEP GENOMICS (Canada)
Cyclica (Canada)
BenevolentAI (UK)
Exscientia (UK)
Iktos (France)

Types list
Software
Service

Application list
Target Selection and Validation
Drug Screening and Lead Optimization
Clinical Studies
Preclinical studies

Table of Content

1 AI in Drug Discovery Market Introduction and Overview
1.1 AI in Drug Discovery Definition
1.2 Market Size Analysis by Types
1.3 Market Size Analysis by Application
1.4 Research Purposes
1.5 Report Timeline
1.6 Economic Analysis of Global Regions
2 Global Market Growth Trends Analysis
2.1 Global AI in Drug Discovery Market Size & Forecast (2019-2030)
2.2 AI in Drug Discovery Growth Trends Analysis by Regions
2.2.1 AI in Drug Discovery Market Size by Regions: 2019 VS 2024 VS 2030
2.2.2 AI in Drug Discovery Historic Market Size by Regions (2019-2024)
2.2.3 AI in Drug Discovery Forecasted Market Size by Regions (2024-2030)
2.2.4 North America AI in Drug Discovery Market Size & Forecast (2019-2030)
2.2.5 Europe AI in Drug Discovery Market Size & Forecast (2019-2030)
2.2.6 Asia-Pacific AI in Drug Discovery Market Size & Forecast (2019-2030)
2.2.7 Latin America AI in Drug Discovery Market Size & Forecast (2019-2030)
2.2.8 Middle East & Africa AI in Drug Discovery Market Size & Forecast (2019-2030)
3 North America
3.1 North America AI in Drug Discovery Revenue by Countries
3.1.1 North America AI in Drug Discovery Revenue by Countries (2019-2030)
3.2 North America AI in Drug Discovery Revenue by Players
3.3 North America AI in Drug Discovery Revenue by Types
3.4 North America AI in Drug Discovery Revenue by Applications
3.5 United States
3.6 Canada
4 Asia Pacific
4.1 Asia Pacific AI in Drug Discovery Revenue by Countries
4.1.1 Asia Pacific AI in Drug Discovery Revenue by Countries (2019-2030)
4.2 Asia Pacific AI in Drug Discovery Revenue by Players
4.3 Asia Pacific AI in Drug Discovery Revenue by Types
4.4 Asia Pacific AI in Drug Discovery Revenue by Applications
4.5 China
4.6 Japan
4.7 Korea
4.8 Southeast Asia
4.9 India
4.10 Australia
5 Europe
5.1 Europe AI in Drug Discovery Revenue by Countries
5.1.1 Europe AI in Drug Discovery Revenue by Countries (2019-2030)
5.2 Europe AI in Drug Discovery Revenue by Players
5.3 Europe AI in Drug Discovery Revenue by Types
5.4 Europe AI in Drug Discovery Revenue by Applications
5.5 Germany
5.6 France
5.7 UK
5.8 Italy
5.9 Russia
5.10 Spain
5.11 Nordic
6 Latin America
6.1 Latin America AI in Drug Discovery Revenue by Countries
6.1.1 Latin America AI in Drug Discovery Revenue by Countries (2019-2030)
6.2 Latin America AI in Drug Discovery Revenue by Players
6.3 Latin America AI in Drug Discovery Revenue by Types
6.4 Latin America AI in Drug Discovery Revenue by Applications
6.5 Brazil
6.6 Argentina
6.7 Colombia
6.8 Mexico
7 Middle East & Africa
7.1 Middle East & Africa AI in Drug Discovery Revenue by Countries
7.1.1 Middle East & Africa AI in Drug Discovery Revenue by Countries (2019-2030)
7.2 Middle East & Africa AI in Drug Discovery Revenue by Players
7.3 Middle East & Africa AI in Drug Discovery Revenue by Types
7.4 Middle East & Africa AI in Drug Discovery Revenue by Applications
7.5 Egypt
7.6 South Africa
7.7 Israel
7.8 Turkey
7.9 GCC Countries
8 Global AI in Drug Discovery Historical and Forecast Market Analysis by Type
8.1 Global AI in Drug Discovery Revenue and Market Share by Type
8.2 Global AI in Drug Discovery Market Forecast by Type (2024-2030)
9 Global AI in Drug Discovery Historical and Forecast Market Analysis by Application
9.1 Global AI in Drug Discovery Revenue Market Share by Application (2019-2024)
9.2 AI in Drug Discovery Market Forecast by Application (2024-2030)
10 AI in Drug Discovery Industry Dynamic Analysis
10.1 AI in Drug Discovery Market Trends Analysis
10.2 AI in Drug Discovery Market Drivers Analysis
10.3 AI in Drug Discovery Market Challenges Analysis
10.4 AI in Drug Discovery Market Restraints Analysis
10.5 AI in Drug Discovery Industry Mergers & Acquisitions
10.6 AI in Drug Discovery Industry New Entrants and Expansion Plans
11 Players Profiles
11.1 GNS Healthcare (US)
11.1.1 GNS Healthcare (US) Company Profile
11.1.2 AI in Drug Discovery Product Overview
11.1.3 GNS Healthcare (US) AI in Drug Discovery Market Performance (2019-2024)
11.1.4 GNS Healthcare (US) Business Overview
11.2 BioSymetrics (US)
11.2.1 BioSymetrics (US) Company Profile
11.2.2 AI in Drug Discovery Product Overview
11.2.3 BioSymetrics (US) AI in Drug Discovery Market Performance (2019-2024)
11.2.4 BioSymetrics (US) Business Overview
11.3 BPGbio, Inc (US)
11.3.1 BPGbio, Inc (US) Company Profile
11.3.2 AI in Drug Discovery Product Overview
11.3.3 BPGbio, Inc (US) AI in Drug Discovery Market Performance (2019-2024)
11.3.4 BPGbio, Inc (US) Business Overview
11.4 Atomwise Inc (US)
11.4.1 Atomwise Inc (US) Company Profile
11.4.2 AI in Drug Discovery Product Overview
11.4.3 Atomwise Inc (US) AI in Drug Discovery Market Performance (2019-2024)
11.4.4 Atomwise Inc (US) Business Overview
11.5 Insitro (US)
11.5.1 Insitro (US) Company Profile
11.5.2 AI in Drug Discovery Product Overview
11.5.3 Insitro (US) AI in Drug Discovery Market Performance (2019-2024)
11.5.4 Insitro (US) Business Overview
11.6 NVIDIA Corporation (US)
11.6.1 NVIDIA Corporation (US) Company Profile
11.6.2 AI in Drug Discovery Product Overview
11.6.3 NVIDIA Corporation (US) AI in Drug Discovery Market Performance (2019-2024)
11.6.4 NVIDIA Corporation (US) Business Overview
11.7 IBM Corporation (US)
11.7.1 IBM Corporation (US) Company Profile
11.7.2 AI in Drug Discovery Product Overview
11.7.3 IBM Corporation (US) AI in Drug Discovery Market Performance (2019-2024)
11.7.4 IBM Corporation (US) Business Overview
11.8 Microsoft Corporation (US)
11.8.1 Microsoft Corporation (US) Company Profile
11.8.2 AI in Drug Discovery Product Overview
11.8.3 Microsoft Corporation (US) AI in Drug Discovery Market Performance (2019-2024)
11.8.4 Microsoft Corporation (US) Business Overview
11.9 Aria Pharmaceuticals, Inc. (US)
11.9.1 Aria Pharmaceuticals, Inc. (US) Company Profile
11.9.2 AI in Drug Discovery Product Overview
11.9.3 Aria Pharmaceuticals, Inc. (US) AI in Drug Discovery Market Performance (2019-2024)
11.9.4 Aria Pharmaceuticals, Inc. (US) Business Overview
11.10 Insilico Medicine (US)
11.10.1 Insilico Medicine (US) Company Profile
11.10.2 AI in Drug Discovery Product Overview
11.10.3 Insilico Medicine (US) AI in Drug Discovery Market Performance (2019-2024)
11.10.4 Insilico Medicine (US) Business Overview
11.11 NuMedii, Inc. (US)
11.11.1 NuMedii, Inc. (US) Company Profile
11.11.2 AI in Drug Discovery Product Overview
11.11.3 NuMedii, Inc. (US) AI in Drug Discovery Market Performance (2019-2024)
11.11.4 NuMedii, Inc. (US) Business Overview
11.12 Owkin Inc. (US)
11.12.1 Owkin Inc. (US) Company Profile
11.12.2 AI in Drug Discovery Product Overview
11.12.3 Owkin Inc. (US) AI in Drug Discovery Market Performance (2019-2024)
11.12.4 Owkin Inc. (US) Business Overview
11.13 Schrödinger, Inc. (US)
11.13.1 Schrödinger, Inc. (US) Company Profile
11.13.2 AI in Drug Discovery Product Overview
11.13.3 Schrödinger, Inc. (US) AI in Drug Discovery Market Performance (2019-2024)
11.13.4 Schrödinger, Inc. (US) Business Overview
11.14 DEEP GENOMICS (Canada)
11.14.1 DEEP GENOMICS (Canada) Company Profile
11.14.2 AI in Drug Discovery Product Overview
11.14.3 DEEP GENOMICS (Canada) AI in Drug Discovery Market Performance (2019-2024)
11.14.4 DEEP GENOMICS (Canada) Business Overview
11.15 Cyclica (Canada)
11.15.1 Cyclica (Canada) Company Profile
11.15.2 AI in Drug Discovery Product Overview
11.15.3 Cyclica (Canada) AI in Drug Discovery Market Performance (2019-2024)
11.15.4 Cyclica (Canada) Business Overview
11.16 BenevolentAI (UK)
11.16.1 BenevolentAI (UK) Company Profile
11.16.2 AI in Drug Discovery Product Overview
11.16.3 BenevolentAI (UK) AI in Drug Discovery Market Performance (2019-2024)
11.16.4 BenevolentAI (UK) Business Overview
11.17 Exscientia (UK)
11.17.1 Exscientia (UK) Company Profile
11.17.2 AI in Drug Discovery Product Overview
11.17.3 Exscientia (UK) AI in Drug Discovery Market Performance (2019-2024)
11.17.4 Exscientia (UK) Business Overview
11.18 Iktos (France)
11.18.1 Iktos (France) Company Profile
11.18.2 AI in Drug Discovery Product Overview
11.18.3 Iktos (France) AI in Drug Discovery Market Performance (2019-2024)
11.18.4 Iktos (France) Business Overview
12 Research Findings and Conclusion

List of Tables and Figures

Figure AI in Drug Discovery Picture
Table Product Definition of AI in Drug Discovery
Table Global AI in Drug Discovery Market Share by Type (2024 VS 2030)
Table Global AI in Drug Discovery Market Share by Application (2024 VS 2030)
Figure Global AI in Drug Discovery Market Size & Forecast (2019-2030)
Table AI in Drug Discovery Market Size by Regions: 2019 VS 2024 VS 2030
Table AI in Drug Discovery Historic Market Size by Regions (2019-2024)
Table AI in Drug Discovery Historic Market Share by Regions (2019-2024)
Table AI in Drug Discovery Forecasted Market Size by Regions (2024-2030)
Table AI in Drug Discovery Forecasted Market Share by Regions (2024-2030)
Figure North America AI in Drug Discovery Market Size & Forecast (2019-2030)
Figure Europe AI in Drug Discovery Market Size & Forecast (2019-2030)
Figure Asia-Pacific AI in Drug Discovery Market Size & Forecast (2019-2030)
Figure Latin America AI in Drug Discovery Market Size & Forecast (2019-2030)
Figure Middle East & Africa AI in Drug Discovery Market Size & Forecast (2019-2030)
Table North America AI in Drug Discovery Revenue by Countries (2019-2030)
Table North America AI in Drug Discovery Revenue Market Share by Countries (2019-2030)
Table North America AI in Drug Discovery Revenue Share by Players 2023
Table North America AI in Drug Discovery Revenue by Types (2019-2024)
Table North America AI in Drug Discovery Revenue Market Share by Types (2019-2024)
Table North America AI in Drug Discovery Revenue by Applications (2019-2024)
Table North America AI in Drug Discovery Revenue Market Share by Applications (2019-2024)
Figure United States AI in Drug Discovery Revenue and Growth (2019-2030)
Figure Canada AI in Drug Discovery Revenue and Growth (2019-2030)
Table Asia-Pacific AI in Drug Discovery Revenue by Countries (2019-2030)
Table Asia-Pacific AI in Drug Discovery Revenue Market Share by Countries (2019-2030)
Table Asia Pacific AI in Drug Discovery Revenue Share by Players 2023
Table Asia Pacific AI in Drug Discovery Revenue by Types (2019-2024)
Table Asia Pacific AI in Drug Discovery Revenue Market Share by Types (2019-2024)
Table Asia Pacific AI in Drug Discovery Revenue by Applications (2019-2024)
Table Asia Pacific AI in Drug Discovery Revenue Market Share by Applications (2019-2024)
Figure China AI in Drug Discovery Revenue and Growth (2019-2030)
Figure Japan AI in Drug Discovery Revenue and Growth (2019-2030)
Figure Korea AI in Drug Discovery Revenue and Growth (2019-2030)
Figure Southeast Asia AI in Drug Discovery Revenue and Growth (2019-2030)
Figure India AI in Drug Discovery Revenue and Growth (2019-2030)
Figure Australia AI in Drug Discovery Revenue and Growth (2019-2030)
Table Europe AI in Drug Discovery Revenue by Countries (2019-2030)
Table Europe AI in Drug Discovery Revenue Market Share by Countries (2019-2030)
Table Europe AI in Drug Discovery Revenue Share by Players 2023
Table Europe AI in Drug Discovery Revenue by Types (2019-2024)
Table Europe AI in Drug Discovery Revenue Market Share by Types (2019-2024)
Table Europe AI in Drug Discovery Revenue by Applications (2019-2024)
Table Europe AI in Drug Discovery Revenue Market Share by Applications (2019-2024)
Figure Germany AI in Drug Discovery Revenue and Growth (2019-2030)
Figure France AI in Drug Discovery Revenue and Growth (2019-2030)
Figure UK AI in Drug Discovery Revenue and Growth (2019-2030)
Figure Italy AI in Drug Discovery Revenue and Growth (2019-2030)
Figure Russia AI in Drug Discovery Revenue and Growth (2019-2030)
Figure Spain AI in Drug Discovery Revenue and Growth (2019-2030)
Figure Nordic AI in Drug Discovery Revenue and Growth (2019-2030)
Table Latin America AI in Drug Discovery Revenue by Countries (2019-2030)
Table Latin America AI in Drug Discovery Revenue Market Share by Countries (2019-2030)
Table Latin America AI in Drug Discovery Revenue Share by Players 2023
Table Latin America AI in Drug Discovery Revenue by Types (2019-2024)
Table Latin America AI in Drug Discovery Revenue Market Share by Types (2019-2024)
Table Latin America AI in Drug Discovery Revenue by Applications (2019-2024)
Table Latin America AI in Drug Discovery Revenue Market Share by Applications (2019-2024)
Figure Brazil AI in Drug Discovery Revenue and Growth (2019-2030)
Figure Argentina AI in Drug Discovery Revenue and Growth (2019-2030)
Figure Colombia AI in Drug Discovery Revenue and Growth (2019-2030)
Figure Mexico AI in Drug Discovery Revenue and Growth (2019-2030)
Table Middle East & Africa AI in Drug Discovery Revenue by Countries (2019-2030)
Table Middle East & Africa AI in Drug Discovery Revenue Market Share by Countries (2019-2030)
Table Latin America AI in Drug Discovery Revenue Share by Players 2023
Table Middle East & Africa AI in Drug Discovery Revenue by Types (2019-2024)
Table Middle East & Africa AI in Drug Discovery Revenue Market Share by Types (2019-2024)
Table Middle East & Africa AI in Drug Discovery Revenue by Applications (2019-2024)
Table Middle East & Africa AI in Drug Discovery Revenue Market Share by Applications (2019-2024)
Figure Egypt AI in Drug Discovery Revenue and Growth (2019-2030)
Figure South Africa AI in Drug Discovery Revenue and Growth (2019-2030)
Figure Israel AI in Drug Discovery Revenue and Growth (2019-2030)
Figure Turkey AI in Drug Discovery Revenue and Growth (2019-2030)
Figure GCC Countries AI in Drug Discovery Revenue and Growth (2019-2030)
Table Global AI in Drug Discovery Revenue and Market Size by Type (2019-2024)
Table Global AI in Drug Discovery Revenue and Market Share by Type (2019-2024)
Table Global AI in Drug Discovery Market Size Forecast by Type (2024-2030)
Table Global AI in Drug Discovery Market Share Forecast by Type (2024-2030)
Table Global AI in Drug Discovery Revenue Market Size by Application (2019-2024)
Table Global AI in Drug Discovery Revenue Market Share by Application (2019-2024)
Table Global AI in Drug Discovery Revenue Market Size by Application (2024-2030)
Table Global AI in Drug Discovery Revenue Market Share by Application (2024-2030)
Table Market Trends Analysis
Table Market Drivers Analysis
Table Market Challenges Analysis
Table Market Restraints Analysis
Table Market Mergers & Acquisitions
Table Market New Entrants and Expansion Plans
Table GNS Healthcare (US) Profile
Table Product Overview
Table GNS Healthcare (US) AI in Drug Discovery Revenue, Gross and Gross Margin (2019-2024)
Figure GNS Healthcare (US) Revenue and Growth Rate
Figure GNS Healthcare (US) Revenue Market Share 2019-2024
Table Business Overview
Table BioSymetrics (US) Profile
Table Product Overview
Table BioSymetrics (US) AI in Drug Discovery Revenue, Gross and Gross Margin (2019-2024)
Figure BioSymetrics (US) Revenue and Growth Rate
Figure BioSymetrics (US) Revenue Market Share 2019-2024
Table Business Overview
Table BPGbio, Inc (US) Profile
Table Product Overview
Table BPGbio, Inc (US) AI in Drug Discovery Revenue, Gross and Gross Margin (2019-2024)
Figure BPGbio, Inc (US) Revenue and Growth Rate
Figure BPGbio, Inc (US) Revenue Market Share 2019-2024
Table Business Overview
Table Atomwise Inc (US) Profile
Table Product Overview
Table Atomwise Inc (US) AI in Drug Discovery Revenue, Gross and Gross Margin (2019-2024)
Figure Atomwise Inc (US) Revenue and Growth Rate
Figure Atomwise Inc (US) Revenue Market Share 2019-2024
Table Business Overview
Table Insitro (US) Profile
Table Product Overview
Table Insitro (US) AI in Drug Discovery Revenue, Gross and Gross Margin (2019-2024)
Figure Insitro (US) Revenue and Growth Rate
Figure Insitro (US) Revenue Market Share 2019-2024
Table Business Overview
Table NVIDIA Corporation (US) Profile
Table Product Overview
Table NVIDIA Corporation (US) AI in Drug Discovery Revenue, Gross and Gross Margin (2019-2024)
Figure NVIDIA Corporation (US) Revenue and Growth Rate
Figure NVIDIA Corporation (US) Revenue Market Share 2019-2024
Table Business Overview
Table IBM Corporation (US) Profile
Table Product Overview
Table IBM Corporation (US) AI in Drug Discovery Revenue, Gross and Gross Margin (2019-2024)
Figure IBM Corporation (US) Revenue and Growth Rate
Figure IBM Corporation (US) Revenue Market Share 2019-2024
Table Business Overview
Table Microsoft Corporation (US) Profile
Table Product Overview
Table Microsoft Corporation (US) AI in Drug Discovery Revenue, Gross and Gross Margin (2019-2024)
Figure Microsoft Corporation (US) Revenue and Growth Rate
Figure Microsoft Corporation (US) Revenue Market Share 2019-2024
Table Business Overview
Table Aria Pharmaceuticals, Inc. (US) Profile
Table Product Overview
Table Aria Pharmaceuticals, Inc. (US) AI in Drug Discovery Revenue, Gross and Gross Margin (2019-2024)
Figure Aria Pharmaceuticals, Inc. (US) Revenue and Growth Rate
Figure Aria Pharmaceuticals, Inc. (US) Revenue Market Share 2019-2024
Table Business Overview
Table Insilico Medicine (US) Profile
Table Product Overview
Table Insilico Medicine (US) AI in Drug Discovery Revenue, Gross and Gross Margin (2019-2024)
Figure Insilico Medicine (US) Revenue and Growth Rate
Figure Insilico Medicine (US) Revenue Market Share 2019-2024
Table Business Overview
Table NuMedii, Inc. (US) Profile
Table Product Overview
Table NuMedii, Inc. (US) AI in Drug Discovery Revenue, Gross and Gross Margin (2019-2024)
Figure NuMedii, Inc. (US) Revenue and Growth Rate
Figure NuMedii, Inc. (US) Revenue Market Share 2019-2024
Table Business Overview
Table Owkin Inc. (US) Profile
Table Product Overview
Table Owkin Inc. (US) AI in Drug Discovery Revenue, Gross and Gross Margin (2019-2024)
Figure Owkin Inc. (US) Revenue and Growth Rate
Figure Owkin Inc. (US) Revenue Market Share 2019-2024
Table Business Overview
Table Schrödinger, Inc. (US) Profile
Table Product Overview
Table Schrödinger, Inc. (US) AI in Drug Discovery Revenue, Gross and Gross Margin (2019-2024)
Figure Schrödinger, Inc. (US) Revenue and Growth Rate
Figure Schrödinger, Inc. (US) Revenue Market Share 2019-2024
Table Business Overview
Table DEEP GENOMICS (Canada) Profile
Table Product Overview
Table DEEP GENOMICS (Canada) AI in Drug Discovery Revenue, Gross and Gross Margin (2019-2024)
Figure DEEP GENOMICS (Canada) Revenue and Growth Rate
Figure DEEP GENOMICS (Canada) Revenue Market Share 2019-2024
Table Business Overview
Table Cyclica (Canada) Profile
Table Product Overview
Table Cyclica (Canada) AI in Drug Discovery Revenue, Gross and Gross Margin (2019-2024)
Figure Cyclica (Canada) Revenue and Growth Rate
Figure Cyclica (Canada) Revenue Market Share 2019-2024
Table Business Overview
Table BenevolentAI (UK) Profile
Table Product Overview
Table BenevolentAI (UK) AI in Drug Discovery Revenue, Gross and Gross Margin (2019-2024)
Figure BenevolentAI (UK) Revenue and Growth Rate
Figure BenevolentAI (UK) Revenue Market Share 2019-2024
Table Business Overview
Table Exscientia (UK) Profile
Table Product Overview
Table Exscientia (UK) AI in Drug Discovery Revenue, Gross and Gross Margin (2019-2024)
Figure Exscientia (UK) Revenue and Growth Rate
Figure Exscientia (UK) Revenue Market Share 2019-2024
Table Business Overview
Table Iktos (France) Profile
Table Product Overview
Table Iktos (France) AI in Drug Discovery Revenue, Gross and Gross Margin (2019-2024)
Figure Iktos (France) Revenue and Growth Rate
Figure Iktos (France) Revenue Market Share 2019-2024
Table Business Overview
Table Research Findings and Conclusion